Stereotaxis, the global leader in robotic technologies for the treatment of cardiac arrhythmias, announced the first treatment of patients with a newly launched Genesis Robotic Magnetic Navigation (RMN) system at Advocate Christ Medical Center in Chicago, Illinois.
Advocate Christ Medical Center, a part of Advocate Health, is the leading provider of robotic heart rhythm care in the Midwest. Electrophysiologists at the hospital have treated over 2,000 patients using advanced robotic technology. The hospital is now among the first in the world, and the first in Chicago, to offer the Genesis RMN system to patients.
“At Advocate Christ, we take pride in providing the highest quality care,” said Dr. Jeffrey Neiger, Cardiac Electrophysiologist at Advocate Christ Medical Center. “For more than a decade, our electrophysiology team has leveraged the precision and safety of robotics when treating our cardiac patients. With the adoption of Genesis, we are extending our commitment to that technological and clinical leadership.”
Robotic Magnetic Navigation introduces the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias. Tens of millions of individuals worldwide suffer from arrhythmias – abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.
“We are excited to continue our partnership with Advocate Christ in advancing the frontiers of patient care and clinical science in cardiology,” said David Fischel, Chairman and CEO of Stereotaxis. “We look forward to working with them in ensuring the best possible heart care is available to the Chicago community.”
